Literature DB >> 9701248

T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses.

T Fehr1, H Y Naim, M F Bachmann, A F Ochsenbein, P Spielhofer, E Bucher, H Hengartner, M A Billeter, R M Zinkernagel.   

Abstract

B-cell activation depends on the intensity of B-cell receptor cross-linking. Studies of haptenated antigens and vesicular stomatitis virus (VSV) have demonstrated a correlation between antigen repetitiveness and the degree to which B-cell activation is independent of T cells. Here, we compare neutralizing antibody responses to inactivated VSV with those to two inactivated human pathogenic viruses: highly cytopathic poliovirus (PV) and poorly cytopathic measles virus (MV). The rigidly structured PV efficiently induced neutralizing IgM antibodies independent of T cells. In contrast, neutralizing antibodies to the pleomorphic MV were dependent on helper T cells. To test whether this resulted from the differences in virus structure or the capacity of MV to induce cell fusion and/or immunosuppression, we analyzed antibody responses to chimeric MV expressing VSV glycoprotein instead of MV fusion protein and hemagglutinin. IgM antibodies were independent of T cells; in addition, we found IgG responses dependent on T-cell help that were enduring and protective against lethal VSV infection. Because chimeric MV viruses look like MV ultrastructurally, we conclude that not only structural differences in the envelope but also the ability of MV to induce immunosuppression may limit its capacity to directly activate B cells. These findings are relevant for our understanding of B-cell activation by two prototypic human pathogenic viruses and for the design of new recombinant vaccines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701248     DOI: 10.1038/nm0898-945

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  21 in total

1.  Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics.

Authors:  Maryam Ahmadi; Christine J Bryson; Edward A Cloake; Katie Welch; Vasco Filipe; Stefan Romeijn; Andrea Hawe; Wim Jiskoot; Matthew P Baker; Mark H Fogg
Journal:  Pharm Res       Date:  2015-04       Impact factor: 4.200

2.  Immunogenicity of protein therapeutics: The key causes, consequences and challenges.

Authors:  Matthew P Baker; Helen M Reynolds; Brooke Lumicisi; Christine J Bryson
Journal:  Self Nonself       Date:  2010-10

3.  Major carbohydrate antigen of Echinococcus multilocularis induces an immunoglobulin G response independent of alphabeta+ CD4+ T cells.

Authors:  W J Dai; A Hemphill; A Waldvogel; K Ingold; P Deplazes; H Mossmann; B Gottstein
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.

Authors:  Elizabeth M Sitati; Michael S Diamond
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

Review 5.  Measles virus.

Authors:  Hussein Y Naim
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

6.  Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response.

Authors:  Cristina L Swanson; Timothy J Wilson; Pamela Strauch; Marco Colonna; Roberta Pelanda; Raul M Torres
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

7.  The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation.

Authors:  Sarah E Blutt; Sue E Crawford; Kelly L Warfield; Dorothy E Lewis; Mary K Estes; Margaret E Conner
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression.

Authors:  Julien C Marie; Frédéric Saltel; Jean-Michel Escola; Pierre Jurdic; T Fabian Wild; Branka Horvat
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 9.  IgM in microbial infections: taken for granted?

Authors:  Rachael Racine; Gary M Winslow
Journal:  Immunol Lett       Date:  2009-06-17       Impact factor: 3.685

10.  Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.

Authors:  Marc C Levesque; M Anthony Moody; Kwan-Ki Hwang; Dawn J Marshall; John F Whitesides; Joshua D Amos; Thaddeus C Gurley; Sallie Allgood; Benjamin B Haynes; Nathan A Vandergrift; Steven Plonk; Daniel C Parker; Myron S Cohen; Georgia D Tomaras; Paul A Goepfert; George M Shaw; Jörn E Schmitz; Joseph J Eron; Nicholas J Shaheen; Charles B Hicks; Hua-Xin Liao; Martin Markowitz; Garnett Kelsoe; David M Margolis; Barton F Haynes
Journal:  PLoS Med       Date:  2009-07-07       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.